Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Surgery Partners

Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2022

Surgery Partners Earnings Perspective: Return On Invested Capital

Surgery Partners Earnings Perspective: Return On Invested Capital

Pulled from Benzinga Pro data, Surgery Partners (NASDAQ:SGRY) posted Q1 earnings of $42.80 million, an increase from Q4 of 0.23%. Sales dropped to $596.20 million, a 2.29% decrease between quarters.

Analyst Ratings for Surgery Partners

Analyst Ratings for Surgery Partners

Analysts have provided the following ratings for Surgery Partners (NASDAQ:SGRY) within the last quarter:

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Recap: Surgery Partners Q1 Earnings

Surgery Partners (NASDAQ:SGRY) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Airbnb And 3 Other Stocks Insiders Are Selling

Although gold futures traded higher this morning on Tuesday, there were a few notable insider trades.

Where Surgery Partners Stands With Analysts

Within the last quarter, Surgery Partners (NASDAQ:SGRY) has observed the following analyst ratings:

Surgery Partners: Q4 Earnings Insights

Surgery Partners (NASDAQ:SGRY) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

inkl

Read news from The Economist, FT, and more,
with one subscription

Analyst Ratings For Surgery Partners

Analyst Ratings For Surgery Partners

Over the past 3 months, 6 analysts have published their opinion on Surgery Partners (NASDAQ:SGRY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

1

Organisations

B of A Securities

Robinhood Markets

Spotify Technology

Digital Realty Trust

Progress Software Corporation

B.Riley Securities

Oak Street Health

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play